This advanced NGS-based panel analyzes genes associated with congenital hypopituitarism, a condition in which the pituitary gland fails to produce essential hormones from birth. Metropolis Healthcare performs high-depth sequencing to identify pathogenic variants affecting pituitary development and function. The test helps confirm diagnosis, guide hormone replacement strategies, and support long-term clinical management. A blood sample collected in an EDTA vial is required for analysis.
Price:
Rs. 21,000.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes:G0180
Frequently Asked Questions (FAQ's):
What does the Congenital Hypopituitarism Gene Panel include at Metropolis Healthcare?
It includes targeted sequencing of genes involved in pituitary development and hormone regulation.
How does Metropolis Healthcare perform this genetic test?
Metropolis Healthcare uses high-precision Next-Generation Sequencing with expert bioinformatic analysis to detect clinically relevant variants.
Who should consider taking this test at Metropolis Healthcare?
Infants, children, or adults with growth failure, delayed puberty, or suspected pituitary hormone deficiencies may benefit.
What type of sample is required for this panel at Metropolis Healthcare?
A blood sample collected in an EDTA tube is needed for sequencing.
How can this test help in clinical management?
It confirms the genetic cause, supports individualized hormone therapy, and helps predict long-term outcomes.
How long does Metropolis Healthcare take to deliver the results?
Results are generally available within 2–4 weeks depending on analysis complexity.
Can this panel detect carriers of congenital hypopituitarism?
Yes, the test can identify carriers, which is helpful for family planning and genetic counseling.
Is genetic counseling recommended after this test at Metropolis Healthcare?
Yes, counseling assists in interpreting results and understanding inheritance patterns.